Generic Manufacturers May Gain Edge In New Patent Challenge Procedure At PTO
Executive Summary
Apotex’s challenge of Alcon’s Vigamox patent put PTO’s new inter partes review proceeding in the spotlight; 45 petitions have been filed in the biopharma sector.